Literature DB >> 21566012

TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells.

Stuart S Hobbs1, Jeremy A Goettel, Dongchun Liang, Fang Yan, Karen L Edelblum, Mark R Frey, Matthew T Mullane, D Brent Polk.   

Abstract

TNF and epidermal growth factor (EGF) are well-known stimuli of cyclooxygenase (COX)-2 expression, and TNF stimulates transactivation of EGF receptor (EGFR) signaling to promote survival in colon epithelial cells. We hypothesized that COX-2 induction and cell survival signaling downstream of TNF are mediated by EGFR transactivation. TNF treatment was more cytotoxic to COX-2(-/-) mouse colon epithelial (MCE) cells than wild-type (WT) young adult mouse colon (YAMC) epithelial cells or COX-1(-/-) cells. TNF also induced COX-2 protein and mRNA expression in YAMC cells, but blockade of EGFR kinase activity or expression inhibited COX-2 upregulation. TNF-induced COX-2 expression was reduced and absent in EGFR(-/-) and TNF receptor-1 (TNFR1) knockout MCE cells, respectively, but was restored upon expression of the WT receptors. Inhibition of mediators of EGFR transactivation, Src family kinases and p38 MAPK, blocked TNF-induced COX-2 protein and mRNA expression. Finally, TNF injection increased COX-2 expression in colon epithelium of WT, but not kinase-defective EGFR(wa2) and EGFR(wa5), mice. These data indicate that TNFR1-dependent transactivation of EGFR through a p38- and/or an Src-dependent mechanism stimulates COX-2 expression to promote cell survival. This highlights an EGFR-dependent cell signaling pathway and response that may be significant in colitis-associated carcinoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566012      PMCID: PMC3154604          DOI: 10.1152/ajpgi.00383.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  78 in total

1.  The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia.

Authors:  S N Agoff; T A Brentnall; D A Crispin; S L Taylor; S Raaka; R C Haggitt; M W Reed; I A Afonina; P S Rabinovitch; A C Stevens; Z Feng; M P Bronner
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase.

Authors:  Stuart S Hobbs; Elizabeth M Cameron; Robert P Hammer; Ann T D Le; Richard M Gallo; Erika N Blommel; Stephanie L Coffing; Han Chang; David J Riese
Journal:  Oncogene       Date:  2004-01-29       Impact factor: 9.867

Review 3.  Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.

Authors:  Kyung-Soo Chun; Young-Joon Surh
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

4.  Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication.

Authors:  Gretchen M Argast; Jean S Campbell; John T Brooling; Nelson Fausto
Journal:  J Biol Chem       Date:  2004-06-15       Impact factor: 5.157

5.  Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.

Authors:  Lene Melsaether Grøvdal; Espen Stang; Alexander Sorkin; Inger Helene Madshus
Journal:  Exp Cell Res       Date:  2004-11-01       Impact factor: 3.905

6.  The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.

Authors:  Robin Matuk; Jonathan Crawford; Maria T Abreu; Stephan R Targan; Eric A Vasiliauskas; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2004-07       Impact factor: 5.325

7.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

8.  Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor.

Authors:  Daekee Lee; Sally H Cross; Karen E Strunk; Joanne E Morgan; Candice L Bailey; Ian J Jackson; David W Threadgill
Journal:  Mamm Genome       Date:  2004-07       Impact factor: 2.957

9.  TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine.

Authors:  Terrence E Riehl; Rodney D Newberry; Robin G Lorenz; William F Stenson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-10-02       Impact factor: 4.052

10.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Biol       Date:  1976-10       Impact factor: 10.539

View more
  25 in total

1.  Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis.

Authors:  Laura E Fredenburgh; Margarita M Suárez Velandia; Jun Ma; Torsten Olszak; Manuela Cernadas; Joshua A Englert; Su Wol Chung; Xiaoli Liu; Cynthia Begay; Robert F Padera; Richard S Blumberg; Stephen R Walsh; Rebecca M Baron; Mark A Perrella
Journal:  J Immunol       Date:  2011-10-03       Impact factor: 5.422

2.  TNF-α induces upregulation of EGFR expression and signaling in human colonic myofibroblasts.

Authors:  James Yoo; Citlali Ekaterina Rodriguez Perez; Wenxian Nie; Robert A Edwards; James Sinnett-Smith; Enrique Rozengurt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

Review 3.  The obesity-inflammation-eicosanoid axis in breast cancer.

Authors:  Linda Vona-Davis; David P Rose
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-10-30       Impact factor: 2.673

Review 4.  Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.

Authors:  Sara M Centuori; Jesse D Martinez
Journal:  Dig Dis Sci       Date:  2014-06-11       Impact factor: 3.199

Review 5.  Molecular pathways driving disease-specific alterations of intestinal epithelial cells.

Authors:  Rocío López-Posadas; Markus F Neurath; Imke Atreya
Journal:  Cell Mol Life Sci       Date:  2016-09-13       Impact factor: 9.261

6.  EGFR regulates macrophage activation and function in bacterial infection.

Authors:  Dana M Hardbower; Kshipra Singh; Mohammad Asim; Thomas G Verriere; Danyvid Olivares-Villagómez; Daniel P Barry; Margaret M Allaman; M Kay Washington; Richard M Peek; M Blanca Piazuelo; Keith T Wilson
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

7.  Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.

Authors:  Jamie M Golden; Oswaldo H Escobar; Michelle V L Nguyen; Michael U Mallicote; Patil Kavarian; Mark R Frey; Christopher P Gayer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-19       Impact factor: 4.052

Review 8.  Gut permeability and mucosal inflammation: bad, good or context dependent.

Authors:  R Ahmad; M F Sorrell; S K Batra; P Dhawan; A B Singh
Journal:  Mucosal Immunol       Date:  2017-01-25       Impact factor: 7.313

Review 9.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies.

Authors:  Urs A Boelsterli; Matthew R Redinbo; Kyle S Saitta
Journal:  Toxicol Sci       Date:  2012-10-22       Impact factor: 4.849

10.  Loss of ADAM17-Mediated Tumor Necrosis Factor Alpha Signaling in Intestinal Cells Attenuates Mucosal Atrophy in a Mouse Model of Parenteral Nutrition.

Authors:  Yongjia Feng; Yu-Hwai Tsai; Weidong Xiao; Matthew W Ralls; Alex Stoeck; Carole L Wilson; Elaine W Raines; Daniel H Teitelbaum; Peter J Dempsey
Journal:  Mol Cell Biol       Date:  2015-08-17       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.